Skip to content
GenoLensGenoLens

DPH2

Chr 1p34.1

diphthamide biosynthesis 2

MANE:
ENST00000255108.8

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • developmental delay with short stature, dysmorphic facial features, and sparse hair 2

    0.54
  • neurodegenerative disease

    0.45
  • developmental delay with short stature, dysmorphic facial features, and sparse hair 1

    0.37
  • Global developmental delay

    0.16
  • Short stature

    0.14
  • ventricular septal defect

    0.14
  • Intellectual disability

    0.12
  • Macrocephaly

    0.12
  • hepatocellular carcinoma

    0.08
  • cancer

    0.08

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

2-(3-amino-3-carboxypropyl)histidine synthase subunit 2

Required for the first step of diphthamide biosynthesis, a post-translational modification of histidine which occurs in elongation factor 2 (PubMed:32576952). DPH1 and DPH2 transfer a 3-amino-3-carboxypropyl (ACP) group from S-adenosyl-L-methionine (SAM) to a histidine residue, the reaction is assisted by a reduction system comprising DPH3 and a NADH-dependent reductase (By similarity). Facilitates the reduction of the catalytic iron-sulfur cluster found in the DPH1 subunit (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.